|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.5177 USD | -4.41% |
|
-11.38% | -39.31% |
| 10-14 | Ladenburg Thalmann Initiates Aprea Therapeutics at Buy With $2 Price Target | MT |
| 08-28 | Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| APRE | Delayed | |
CBOE
| APRE | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.6176 | 0.7305 | 0.8386 |
| Spread/Res. | -16.18% | -29.13% | -38.27% |
| Spread/Supp. | +13.41% | +24.15% | +13.61% |
| Support | 0.4565 | 0.417 | 0.4557 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- APRE Stock
- Charts Aprea Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
